Biotechnology
/
Eastern Norway

Fmc Biopolymer AS
ULTRA PURE BIOPOLYMERS FOR PHARMACEUTICAL, BIOTECHNOLOGY AND BIOMEDICAL APPLICATIONS

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 1.352.725
    Operating profit: 217.534
    Operating profit before tax: 261.134
    Total assets: 1.433.435
    Total equity: 1.190.495
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Thomas Aanmoen

    Board Members:
    Flemming Jørgensen
    Flemming Jørgensen
    Per Magne Olsen
    Trond Helgerud

    General Manager:
    Trond Helgerud

    Subsidiary companies:
    Largest shareholders:
    N/A
  • Trademarks
    Lamitex, Protacid, Protaweld, Scogin,
Lamitex, Protacid, Protaweld, Scogin,
    Biomedical equipment, Biotechnology, chemical products and man-made fibres, Chemicals, Health Care, Miscellaneous manufactured and other goods, Pharmaceutical articles, Vegetable oils,